NCT05787379Recruiting
Care for Veterans Post-COVID-19
Leveraging Knowledge of Chronic Multisymptom Illness to Improve Care for Veterans
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
The evidence-based Concordant Care approach involves engaging in processes that: 1) validate the patient's experience, 2) develop a shared understanding of the condition, and 3) create a patient-centered, whole health-oriented action plan to manage the condition. This is consistent with published expert opinion that Concordant Care underlies patients' (and clinicians') positive experiences of care for poorly understood conditions. Despite strong evidence supporting this care approach, there are no interventions to train clinicians on practices to provide Concordant Care for Veterans with poorly understood conditions such as Long-COVID. Part 1 of the study will optimize and test if a Concordant Care training improves VA clinicians' engagement in recommended practices to provide Concordant Care (i.e., validate, shared understanding, action plan) for Veterans with Long-COVID. This study will adapt and refine Concordant Care training for Long-COVID. Part 2 of this study will determine if Concordant Care training increases clinicians' engagement in recommended practices to provide Concordant Care and will explore the effectiveness of Concordant Care on care outcomes including satisfaction, adherence to care, \& disability for Veterans with Long-COVID. Veterans treated by clinicians receiving Concordant Care training will report their clinician more frequently engaged in recommended conversations (i.e., ask about Long-COVID, validate experience with Long-COVID, create a shared understanding and action plan), and Veterans will perceive greater shared understanding of Long-COVID with their clinicians than Veterans treated by clinicians in the control arm.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 348 (estimated)
- First submitted
- 23 Mar 2023
- Start date
- 1 Jan 2025
- Primary completion date
- 30 Nov 2027
- Lead sponsor
- VA Office of Research and Development
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05787379
What you commit to
- Study type: Interventional
- Planned participants: 348
- From 1 Jan 2025 to the primary completion date, 30 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Part 1, Veterans will be excluded if they are not receiving care in the VA.
Other illness
- Part 2, Veterans will be excluded if they were in the Intensive Care Unit (ICU) for COVID-19.
Other
- Part 1 and Part 2, clinicians who have already taken Concordant Care training will be excluded.
Who the study is looking for
- Part 1 and Part 2, English-speaking VA primary care providers will be included.
- Part 1, Veterans who self-identify as having Long-COVID will be included.
- Part 2, Veterans who meet criteria for Long-COVID assessed with modified DePaul Symptom Questionnaire version 2 will be included;
- Part 2, Veterans must also have a scheduled appointment with one of the participating clinicians within one to six months of the clinician being consented.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ Coordinator of this site? Confirm its status | East Orange | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.